These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"]. Gorshkov VA. Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232 [No Abstract] [Full Text] [Related]
3. Suppression of gastric acidity in horses. Murray MJ. J Am Vet Med Assoc; 1997 Jul 01; 211(1):37-40. PubMed ID: 9215408 [No Abstract] [Full Text] [Related]
4. Pharmacological control of human gastric acid secretion. Pounder RE. Postgrad Med J; 1986 Jul 01; 62 Suppl 2():21-5. PubMed ID: 2890148 [No Abstract] [Full Text] [Related]
5. Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. Savarino V, Mela GS, Zentilin P, Sumberaz A, Bonifacino G, Celle G. Am J Gastroenterol; 1991 Mar 01; 86(3):281-4. PubMed ID: 1671805 [Abstract] [Full Text] [Related]
9. Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists active duodenal ulcer. Longstreth GF, Go VL, Malagelada JR. Gastroenterology; 1977 Jan 01; 72(1):9-13. PubMed ID: 11148 [Abstract] [Full Text] [Related]
10. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer. Gabryelewicz A, Sarosiek J, Laszewicz W. Acta Med Pol; 1981 Jan 01; 22(4):335-9. PubMed ID: 6128866 [No Abstract] [Full Text] [Related]
11. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage]. Schepp W. Bildgebung; 1993 Apr 01; 60 Suppl 1():41-4. PubMed ID: 8104063 [No Abstract] [Full Text] [Related]
12. The effect of H2-receptor antagonists on pepsin secretion in man. Gledhill T, Hunt RH. Prog Clin Biol Res; 1985 Apr 01; 173():159-67. PubMed ID: 2858865 [No Abstract] [Full Text] [Related]
13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats. Amagase K, Kato S, Yamamoto H, Okabe S. Arzneimittelforschung; 1996 Feb 01; 46(2):177-84. PubMed ID: 8720310 [Abstract] [Full Text] [Related]
14. [Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases]. Rapoport SI, Khutsishvili MB, Rasulov MI, Trubitsina IE, Raĭkhlin NT. Ter Arkh; 2008 Feb 01; 80(2):86-9. PubMed ID: 18372605 [No Abstract] [Full Text] [Related]
15. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity. Nielsen ST, Dove PA, Strike DP, Schiehser GA. Drugs Exp Clin Res; 1987 Feb 01; 13(5):297-304. PubMed ID: 2890506 [Abstract] [Full Text] [Related]
16. [Histamine H2 receptor antagonists. Pharmacology and clinical applications]. Mignon M, Gislon J, Bonfils S. Rev Prat; 1978 Nov 21; 28(53):4145-6, 4151-2, 4155-8. PubMed ID: 33441 [No Abstract] [Full Text] [Related]
17. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?]. Schepp W. Leber Magen Darm; 1986 Jan 21; 16(1):41-50. PubMed ID: 3959724 [No Abstract] [Full Text] [Related]
18. [Currents aspects of H2 receptor antagonists in the treatment of ulcers]. Debongnie JC. Acta Gastroenterol Belg; 1992 Jan 21; 55(5-6):415-22. PubMed ID: 1363166 [Abstract] [Full Text] [Related]